1 recruiting, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Pain Assessment: new trials by email Literature Review of Pain Assessment trials Research Report on Pain Assessment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment Supplemental Postoperative Bupivacaine, Placebo Injection - Pain Assessment, Quality of Life (QOL) | Phase 2 | Recruiting | New York University | 150 | 2024-11-01 | 2026-11-10 |
| Oxytocin for Hypermobile Ehlers-Danlos Syndrome Oxytocin, Placebo - Hypermobile Ehlers-Danlos Syndrome, Pain Assessment | Phase 1 / Phase 2 | Terminated | Baylor College of Medicine | 2 | 2022-05-13 | 2025-08-28 |
Agnosia (1) · Ehlers-Danlos syndrome type 3 (1) · Pain (1)
Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Perceptual Disorders (1)
Oxytocin (1)
Baylor College of Medicine (1) · New York University (1)
United States (2)